Freenome, Inc. (FRNM)

NASDAQ: FRNM · USD

$13.5

+0.42 (+3.2%)· Recorded snapshot

Market cap	1.4B
Revenue (ttm)	35.4M
Net income (ttm)	-235.3M
EPS (ttm)	-$8.84
Shares out	107.4M
Volume	389,312
Beta	0.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 35.4M
Net income (ttm): -235.3M
EPS (ttm): -$8.84
Market cap: 1.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Manter

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROEn/a

P25 -113.8P50 -46.5P75 -0.9

ROICn/a

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All FRNM indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002017526
Company name	Freenome, Inc.
Country	United States
Country code	US
CUSIP number	35661P100
Earnings date	2026-11-10
Earnings time	amc
Employees	381
Enterprise value	$1.7B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-23
Fiscal year end	December
Founded	2014
Industry	Diagnostics & Research
Is primary listing	Yes
Is SPAC	No
ISIN number	US35661P1003
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.4B
Market cap category	Small-Cap
Next earnings date	2026-11-10
Options	No
Price	$13.46
Price currency	USD
Sector	Healthcare
Stock price date	2026-10-28
Symbol	FRNM
U.S. state	California
Website	https://www.freenome.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-65.66%
EV/Sales	46.82x
FCF / EV yield	-7.49%
FCF yield	-8.57%
Forward EV/Sales	12.11x
Forward P/S	10.58x
Industry forward P/E	30.92x
Industry P/E	50.57x
P/S ratio	40.9x
Sector forward P/E	23.56x
Sector P/E	50.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-651.4%
Pretax margin	-664.57%
Profit per employee	$-617,654
Revenue per employee	$92,940
ROCE	-79.27%
SBC / revenue	31.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Net income growth years	1
Revenue growth	1,128.66%
Revenue growth (Q)	106.54%
Revenue growth (QoQ)	-46.14%
Revenue growth quarters	2
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-16M
Depreciation and amortization	$24.7M
EBIT	$-230.7M
EBITDA	$-206M
EPS	$-8.84
FCF per share	$-1.16
Financing cash flow	$94.6M
Free cash flow	$-124.1M
Free cash flow minus SBC	$-135.3M
Gross profit	$-175.2M
Investing cash flow	$39.3M
Net borrowing	$101.1M
Net cash flow	$25.7M
Net income	$-235.3M
Operating cash flow minus SBC	$-119.3M
Operating income	$-230.7M
Revenue	$35.4M
Stock-based compensation	$11.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-6.82
Book value per share	$-52.92
Goodwill	$10.5M
Interest coverage	-21.6
Long-term assets	$285.2M
Long-term liabilities	$317.6M
Net cash (debt)	$-209.4M
Net cash / market cap	-14.46%
Piotroski F-Score	2
Property, plant and equipment	$252.8M
Shareholders' equity	$-26.6M
Tangible book value	$-1.4B
Tangible book value per share	$-53.43
Total assets	$398.5M
Total cash	$102M
Total debt	$311.5M
Total liabilities	$425.1M
WACC	5.99%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$113.3M
Current liabilities	$107.5M
Current ratio	1.05
Net working capital	$-85.1M
Quick ratio	0.98
Working capital	$5.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.89%
Dividend yield	0%
Shareholder yield	-1.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$12.42
1D price change	3.22%
1M price change	-15.82%
1M total return	-15.82%
1W price change	-3.93%
1W total return	-3.93%
1Y price change	26.03%
1Y return CAGR	26.05%
1Y total return	26.03%
20-day SMA	$14.03
200-day SMA	$12.53
3M price change	18.28%
3M total return	18.28%
50-day SMA	$14.77
50-day SMA vs 200-day SMA	50over200
52-week high	$17.50
52-week high date	2026-09-21
52-week low	$9.95
52-week low date	2026-07-13
6M price change	19.86%
6M total return	19.86%
All-time high	$17.50
All-time high date	2026-09-21
All-time low	$9.95
All-time low date	2026-07-13
Average true range (ATR)	$0.97
Average volume	710.2K
Beta (1Y)	0.4
Beta (2Y)	0.14
Beta (5Y)	0.45
Change from 52-week high	-23.09%
Change from 52-week low	35.28%
Change from all-time high	-23.09%
Change from all-time low	35.28%
Change from open	1.36%
Day's gap	1.84%
Dollar volume	$5.2M
High price	$13.53
Low price	$13.28
Monthly RSI	59.08
Open price	$13.28
Position in 52-week range	72%
Previous close	$13.04
Price vs 150-day SMA	8.36%
Price vs 20-day SMA	-4.06%
Price vs 200-day SMA	7.47%
Price vs 50-day SMA	-8.88%
Relative volume	0.55
RSI	46.15
Sharpe ratio	0.66
Sortino ratio	1.19
Volume	389.3K
Weekly RSI	51.03
YTD price change	3.3%
YTD total return	3.3%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49.8M
Float percentage	46.33%
Shares change (QoQ)	0%
Shares change (YoY)	1.89%
Shares held by insiders	2.2%
Shares held by institutions	10.03%
Shares outstanding	107.4M
Short % of float	6.83%
Short % of shares	3.16%
Short ratio	3.7 days

Deeper analysis on FRNM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRNM report

Is a complete FRNM research report available?

No complete published report is available for Freenome, Inc. (FRNM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Freenome, Inc. (FRNM)

Price

Financial snapshot

Fair-value bridge

Latest news · FRNM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRNM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRNM

Frequently asked questions